By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuroVive Pharmaceutical AB 

Biomedical Center

Sölvegatan 19    SE-221 84 Lund  Sweden
Phone: 46-0-46-288-0110 Fax: 46-0-46-888-8348


NeuroVive Pharmaceutical is a pioneer in mitochondrial research and development. The focus is on developing drug candidates that maintain mitochondrial integrity and improves their function for indications with unmet medical needs. Research and development is conducted both in-house and in collaboration with renowned international partners.




Founder: Eskil Elmér

CEO: Erik Kinnman

CSO and Founder: Eskil Elmér

Key Statistics

Ownership: Public

Web Site: NeuroVive
Symbol: NVP


Company News
NeuroVive (NVP)'s New Generation Of Sanglifehrin-Based Compounds Demonstrate Potent Inhibitory Effects On Human Hepatocellular Cancer Cells 2/2/2017 8:27:38 AM
NeuroVive (NVP) Release: Company Redirects Research Resources From Asian Subsidiary To Parent 1/25/2017 11:56:03 AM
NeuroVive (NVP) Release: Company Signs Mitochondrial Medicine Research Agreement With US Key Opinion Leader 1/23/2017 8:39:45 AM
NeuroVive (NVP) Release: Pharma Presents Positive Preclinical Data In Hepatocellular Cancer At HCC Summit 1/19/2017 8:05:18 AM
NeuroVive (NVP) Release: Company Signs Collaboration Agreement With Karolinska Institute 1/10/2017 6:13:35 AM
NeuroVive (NVP) To Present At The 9th Annual Biotech Showcase Conference 1/5/2017 9:51:29 AM
NeuroVive (NVP) Interim Report January - September 2016 11/22/2016 10:46:32 AM
NeuroVive (NVP) Reports Positive Pre-Clinical Results In NASH 11/1/2016 3:07:57 PM
NeuroVive (NVP) Completes Closure Of Lyon Subsidiary 10/25/2016 11:25:06 AM
NeuroVive (NVP) Ends Deal With Arbutus Biopharma (ABUS), Takes Back Hep B Drug 10/21/2016 5:56:26 AM